Presentation of the results of working group 1.5 in the framework of the 3rd Annual Meeting of National Drug Observatories held in Prague.
1.3 - Test, develop or update evaluation and monitoring tools, processes and tasks, necessary to deepen the knowledge of the drugs situation in CELAC countries with well-established NDOs.
Promoted the establishment in CELAC countries of national EWS, though the onset of sustainable information-sharing agreements between NAs, NDOs and other stakeholders, which can provide key information to assess and deal effectively with the new threats of psychoactive drugs.
The percentage of CELAC participating countries having a national EWS, has increased, at least a 50% (from baseline situation).
Host
EU Reference country (WG)
EU Reference country (WG)
Leader country (WG)
Leader country (WG)
Leader country (WG)
Leader country (WG)
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.